Understanding how physical properties of tumors affect immune cell behavior in head and neck cancer.

Targeting mechanical regulation of monocyte fate in head and neck cancer.

NIH-funded research University of Pennsylvania · NIH-10843181

This study is looking at how the stiffness of the tissue around tumors in head and neck cancer affects immune cells called monocytes, and it hopes to find ways to help these cells become more effective in fighting the cancer, which could lead to better treatment options for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-10843181 on NIH RePORTER

What this research studies

This research investigates how the mechanical properties of the tumor environment influence the behavior of immune cells, specifically monocytes, in head and neck cancer. The study aims to understand how different stiffness levels of the extracellular matrix (ECM) can affect the differentiation of monocytes into dendritic cells, which play a crucial role in the immune response. By using an artificial ECM system, researchers will explore how these mechanical cues can be manipulated to potentially improve immune responses against tumors. This could lead to new therapeutic strategies for patients with head and neck squamous cell carcinoma who currently have limited treatment options.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with head and neck squamous cell carcinoma, particularly those who have not responded well to existing immunotherapies.

Not a fit: Patients with early-stage head and neck cancer or those not diagnosed with squamous cell carcinoma may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective immunotherapies for patients with head and neck cancer.

How similar studies have performed: Other research has shown promise in manipulating immune cell behavior through mechanical properties of the tumor environment, indicating potential for success in this approach.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.